Orig3n, Inc., a Boston-based company pioneering the future of wellness and health through genetics and biotechnology, is offering the Orig3n 2019 Novel Coronavirus (COVID-19) Test under an Emergency Use Authorization (EUA) from FDA, to authorized healthcare providers and institutions nationwide.
April 13, 2020
· 4 min read